4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-045110
CEO sold 2,216 shares at $2.18 ($4,826)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-18 | Sale : show line 1 in the form | −2,216 | $2.18 | $4,826 | 1,051,358 | D |
| Open-market sales · 2,216 sh · avg $2.18 · $4,826 | ||||||
Loading xslF345X06/form4.xml…